CT
ABMD

Caldwell Trust’s Abiomed Inc ABMD Stock Holding History

Caldwell Trust’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-33
Closed -$10.7K – 731
2020
Q4 		$10.7K Hold
33
– – ﹤0.01% 618
2020
Q3 		$9.14K Hold
33
– – ﹤0.01% 623
2020
Q2 		$7.97K Hold
33
– – ﹤0.01% 658
2020
Q1 		$4.79K Sell
33
-100
-75% -$16.6K ﹤0.01% 702
2019
Q4 		$22.7K Buy
+133
New +$24.7K ﹤0.01% 572

Other funds holding ABMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Caldwell Trust's ABMD Position: Q1 2021 in Review

Caldwell Trust sold out of Abiomed Inc (ABMD) in Q1 2021, closing a stake of 33 shares — an estimated $10.7K sold.

Caldwell Trust first reported a position in ABMD in Q4 2019 and held it in 5 quarters. The position peaked at $22.7K in Q4 2019. 488 funds tracked by Wall St. Rank hold ABMD as of Q1 2021.

  • Caldwell Trust reported no remaining Abiomed Inc position as of Q1 2021 after selling out during the quarter.
  • Caldwell Trust sold 33 Abiomed Inc shares in Q1 2021, an estimated $10.7K.
  • Caldwell Trust first reported a position in Abiomed Inc in Q4 2019 and held it in 5 quarters.
  • Caldwell Trust's Abiomed Inc position peaked at $22.7K in Q4 2019.
  • 488 funds tracked by Wall St. Rank held Abiomed Inc as of Q1 2021.

Based on Caldwell Trust's 13F filing for Q1 2021, filed 2 Oct 2025.